Ipswich Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $993K | Buy |
17,229
+2,400
| +16% | +$138K | 0.21% | 87 |
|
|
2026
Q1 | $899K | Sell |
14,829
-1,722
| -10% | -$100K | 0.21% | 91 |
|
|
2025
Q4 | $893K | Hold |
16,551
| – | – | 0.21% | 88 |
|
|
2025
Q3 | $746K | Sell |
16,551
-160
| -1% | -$7.47K | 0.17% | 100 |
|
|
2025
Q2 | $774K | Hold |
16,711
| – | – | 0.19% | 102 |
|
|
2025
Q1 | $1.02M | Sell |
16,711
-1,904
| -10% | -$111K | 0.25% | 81 |
|
|
2024
Q4 | $1.05M | Sell |
18,615
-1,370
| -7% | -$76.5K | 0.25% | 81 |
|
|
2024
Q3 | $1.03M | Sell |
19,985
-270
| -1% | -$12.7K | 0.24% | 85 |
|
|
2024
Q2 | $841K | Sell |
20,255
-50
| -0.2% | -$2.24K | 0.2% | 95 |
|
|
2024
Q1 | $1.1M | Hold |
20,305
| – | – | 0.26% | 81 |
|
|
2023
Q4 | $1.04M | Sell |
20,305
-290
| -1% | -$15.2K | 0.26% | 82 |
|
|
2023
Q3 | $1.2M | Sell |
20,595
-2,550
| -11% | -$156K | 0.33% | 72 |
|
|
2023
Q2 | $1.48M | Hold |
23,145
| – | – | 0.39% | 66 |
|
|
2023
Q1 | $1.6M | Sell |
23,145
-240
| -1% | -$16.9K | 0.44% | 64 |
|
|
2022
Q4 | $1.68M | Sell |
23,385
-75
| -0.3% | -$5.66K | 0.48% | 60 |
|
|
2022
Q3 | $1.67M | Buy |
23,460
+350
| +2% | +$25.4K | 0.53% | 55 |
|
|
2022
Q2 | $1.78M | Buy |
23,110
+133
| +0.6% | +$10.1K | 0.51% | 60 |
|
|
2022
Q1 | $1.68M | Sell |
22,977
-500
| -2% | -$33.6K | 0.42% | 69 |
|
|
2021
Q4 | $1.46M | Sell |
23,477
-215
| -0.9% | -$12.6K | 0.34% | 83 |
|
|
2021
Q3 | $1.4M | Sell |
23,692
-380
| -2% | -$25K | 0.36% | 80 |
|
|
2021
Q2 | $1.61M | Buy |
24,072
+111
| +0.5% | +$7.24K | 0.41% | 68 |
|
|
2021
Q1 | $1.51M | Hold |
23,961
| – | – | 0.43% | 64 |
|
|
2020
Q4 | $1.49M | Sell |
23,961
-2,129
| -8% | -$131K | 0.45% | 64 |
|
|
2020
Q3 | $1.57M | Hold |
26,090
| – | – | 0.5% | 59 |
|
|
2020
Q2 | $1.53M | Sell |
26,090
-1,645
| -6% | -$98.4K | 0.53% | 58 |
|
|
2020
Q1 | $1.55M | Sell |
27,735
-5,902
| -18% | -$361K | 0.61% | 51 |
|
|
2019
Q4 | $2.16M | Buy |
33,637
+4,865
| +17% | +$279K | 0.63% | 51 |
|
|
2019
Q3 | $1.46M | Hold |
28,772
| – | – | 0.46% | 61 |
|
|
2019
Q2 | $1.3M | Hold |
28,772
| – | – | 0.42% | 65 |
|
|
2019
Q1 | $1.37M | Buy |
28,772
+50
| +0.2% | +$2.49K | 0.45% | 62 |
|
|
2018
Q4 | $1.49M | Buy |
28,722
+1,100
| +4% | +$59.1K | 0.55% | 54 |
|
|
2018
Q3 | $1.72M | Sell |
27,622
-45
| -0.2% | -$2.67K | 0.58% | 56 |
|
|
2018
Q2 | $1.53M | Sell |
27,667
-2,000
| -7% | -$108K | 0.7% | 53 |
|
|
2018
Q1 | $1.88M | Buy |
29,667
+1,050
| +4% | +$67.5K | 0.79% | 42 |
|
|
2017
Q4 | $1.75M | Hold |
28,617
| – | – | 0.74% | 44 |
|
|
2017
Q3 | $1.82M | Hold |
28,617
| – | – | 0.82% | 40 |
|
|
2017
Q2 | $1.59M | Sell |
28,617
-600
| -2% | -$32.6K | 0.75% | 43 |
|
|
2017
Q1 | $1.59M | Sell |
29,217
-325
| -1% | -$17.8K | 0.69% | 44 |
|
|
2016
Q4 | $1.73M | Hold |
29,542
| – | – | 0.78% | 44 |
|
|
2016
Q3 | $1.59M | Sell |
29,542
-350
| -1% | -$22.5K | 0.78% | 45 |
|
|
2016
Q2 | $2.2M | Sell |
29,892
-1,620
| -5% | -$114K | 1.09% | 38 |
|
|
2016
Q1 | $2.25M | Buy |
31,512
+812
| +3% | +$51.2K | 1.07% | 38 |
|
|
2015
Q4 | $2.11M | Buy |
30,700
+1,111
| +4% | +$73.4K | 0.95% | 43 |
|
|
2015
Q3 | $1.75M | Sell |
29,589
-310
| -1% | -$19.7K | 0.83% | 45 |
|
|
2015
Q2 | $1.99M | Sell |
29,899
-300
| -1% | -$19.8K | 0.9% | 44 |
|
|
2015
Q1 | $1.95M | Buy |
30,199
+1
| +0% | +$63 | 0.85% | 46 |
|
|
2014
Q4 | $1.78M | Buy |
30,198
+600
| +2% | +$33.8K | 0.76% | 46 |
|
|
2014
Q3 | $1.51M | Sell |
29,598
-1,688
| -5% | -$84.3K | 0.64% | 49 |
|
|
2014
Q2 | $1.52M | Buy |
31,286
+1,690
| +6% | +$83.3K | 0.59% | 51 |
|
|
2014
Q1 | $1.54M | Sell |
29,596
-1,200
| -4% | -$63.9K | 0.66% | 49 |
|
|
2013
Q4 | $1.64M | Sell |
30,796
-988
| -3% | -$50.3K | 0.68% | 47 |
|
|
2013
Q3 | $1.47M | Sell |
31,784
-950
| -3% | -$41.7K | 0.66% | 50 |
|
|
2013
Q2 | $1.46M | Buy |
+32,734
| New | +$1.42M | 0.63% | 52 |
|
Other funds holding BMY
AIM
FWIA
DLA
Ipswich Investment Management's BMY Position: Q2 2026 in Review
Ipswich Investment Management increased its Bristol-Myers Squibb (BMY) stake by 16% in Q2 2026, buying an estimated $138K and bringing the position to 17,229 shares worth $993K. The position accounts for 0.21% of the portfolio, ranked #87.
Ipswich Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.25M in Q1 2016. 936 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Ipswich Investment Management held 17,229 shares of Bristol-Myers Squibb worth $993K as of Q2 2026.
- Ipswich Investment Management bought 2,400 Bristol-Myers Squibb shares in Q2 2026, an estimated $138K.
- Bristol-Myers Squibb made up 0.21% of Ipswich Investment Management's portfolio in Q2 2026, its #87 holding.
- Ipswich Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Ipswich Investment Management's Bristol-Myers Squibb position peaked at $2.25M in Q1 2016.
- 936 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.